The top five tweets: From CAR-T to biotech — what did EPM readers enjoy this week?

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.

5. The FDA’s approval of the first CAR-T cell therapy from Novartis makes it into our top chart in fifth place.

4. Fourth position goes to Sanofi’s news of its completed acquisition of vaccines biotech company, Protein Sciences.

3. The sector response to the government’s Life Sciences Industrial Strategy makes it in at number three.

2. Second place goes to the item on Victoza, which has been demonstrated to reduce the risk of major cardiovascular events in diabetic patients.

1. This week’s top spot goes to the article from Nick Sutcliffe on the biotechnology revolution.